The Effect of an Interleukin Receptor Antagonist (IL-1 ra) on Colonocyte Eicosanoid Release

Mediators of Inflammation

Volumn 5, Issue 6, 1996, Pages 449-452

  Smith, G S ^a   Rieckenberg, C ^a   Longo, W E ^a   Kaminski, D L ^a   Mazuski, J E ^a   Deshpande, Y ^a   Miller, T A ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CACO 2; Colonocytes; Cytokines; Eicosanoids; Inflammation; Leukotrienes; Prostaglandins

Indexed keywords

ICOSANOID; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE;

ARTICLE; CELL LINE; COLON; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL;

EID: 0030444641     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/S0962935196000622     Document Type: Article

References (24)

1. Campbell CA, Walker-Smith JA, Hindocha P, Adinolfi M. Acute phase proteins in chronic inflammatory bowel disease in childhood. J Ped Gastroenterol Nutr 1982; 1: 193–200.
2. Chambers RE, Stross P, Barry RE, Whicher JT. Serum amyloid A protein compared with C-reactive protein, alpha 1-antitrypsin and alpha 1-acid glycoprotein as a monitor of inflammatory bowel disease. Eur J Clin Invest 1987; 17: 460–467.
3. Prantera C, Davoli M, Lorenzetti R, Pallone F, et al. Clinical and laboratory indicators of extent of ulcerative colitis. Serum C-reactive protein helps the most. J Clin Gastroenterol 1988; 10: 41–45.
4. Cubulsky NME, Chan MK, Movat HZ. Acute inflammation and microthrombosis induced by endotoxin, IL-1 and TNF and their implication in gram-negative infection. Lab Investigation 1988; 55: 365–378.
5. Uhich TR, DelCastillo J, Keys M, Granger GA, Ni RX. Kinetics and mechanisms of recombinant human IL-1 and TNFα induced changes in circulating numbers of neutrophils and lymphocytes. J Immun 1987; 139: 3406–3415.
6. Dinarello CA, Cannon JG, Wolff SM, Bemheim HA, Buttler B, Cerami A, Figari IS, Palladino MA, O’Conner JV. TNF is an endogenous pyrogen and induces production of IL-1. J Exp Med 1986; 163: 11433–11450.
7. Sirko S, Bishai I, Coceani F. Prostaglandin formation in the hypothalamus in vivo: effect of pyrogens. Am J Pathol 1989; 256: R616–R624.
8. Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC. Primary structure and functional expression from complementary CDNA of a human IL-1 receptor antagonist. Nature 1990; 343: 336–340.
9. Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimdal PL, Armes LG, Sommer A, Eisenberg SP, Thompson RC. IL-1 receptor antagonist activity of a human IL-1 inhibitor. Nature 1990; 85: 1694–1697.
10. Stratton MD, Chandel B, Deshpande Y, Kaminski DL, Li AP, Vernava AM, Longo WE. The effect of Clostridium difficile toxin on colonocyte prostanoid production. Prostaglandins 1994; 48: 367.
11. Kaminski DL, Amir G, Deshpande Y, Beck D, Li AP. Studies on the etiology of acute acalculous cholecystitis: the effect of lipopolysaccharide of human gallbladder mucosal cells. Prostaglandins 1994; 47: 319–330.
12. Kaminski DL, Feinstein WK, Deshpande YG. The production of experimental cholecystitis by endotoxin. Prostaglandins 1994; 47: 233–237.
13. Wiechelman K, Braun R, Fitzpatric J. Investigation of the bicinchoninic acid protein assay; identification of the groups responsible for color formation. Anal Biochem 1988; 175: 231–237.
14. Rachmilewitz D, Simon PL, Schwartz LW, Griswold DE, Fondacaro JD, Wasserman MA. Inflammatory mediators of experimental colitis in rats. Gastroenterology 1989; 97: 326–337.
15. Rachmilewitz D, Simon PL, Sjogrn R, Fondacaro JD, Wasserman MA, Dodecker E. Investigation of IL-1 activity in the intestinal mucosa of Crohn’s disease (CD) and ulcerative colitis patients. Gastroenterology 1989; 94: A363.
16. Durum SK, Schmidt JA, Oppenheim JJ. Interleukin 1: an immunological perspective. Annu Rev Immunol 1985; 2: 263–287.
17. Elner VM, Streiter RM, Elner SG, Baggiolini M, Lindley I, Kunkel SL. Neutrophil chemotactic factor (IL8) gene expression by cytokinetreated retinal pigment epithelial cells. Am J Pathol 1990; 136: 745–750.
18. Satsangi J, Wolstencroft RA, Cason J, Ainley CC, Dumonde CC, Thompson Rph. Interleukin 1 in Crohn’s disease. Clin Exp Immunol 1987; 67: 594–605.
19. Ulich TR, Busser K, Longmuir KJ. Cytokine and calcium ionophore A23187—mediated arachidonic acid metabolism in neutrophils. Cytokine 1990; 2: 280–286.
20. 4 release from activated neutrophils. Proc Natl Acad Sci USA 1983; 80: 4349–4353.
21. Oshima A, Wakabayashi G, Shimagu M, Yoshida A, Iwata K, Kitajima M. Gastroenterology 1995; 108: A184.
22. 2 on adjuvant arthritis. Nature (London) 1969; 224: 1320.
23. 1 on adjuvant arthritis. Nature (London) 1971; 304–305.
24. Zurier RB, Hoffstein S, Weissmann G. Suppression of active and chronic inflammation in adrenalectomized rats by pharmacologic amounts of prostaglandins. Arthritis Rheum 1973; 16: 606–618.